Aurinia Pharmaceuticals Inc. (AUPH) Revenue 2018–2025
Aurinia Pharmaceuticals Inc. (AUPH) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$283.1MFY2025 · since FY2018: $463,000 → $283.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $283.1M | +20.4% |
| FY2024 | $235.1M | +34.0% |
| FY2023 | $175.5M | +31.0% |
| FY2022 | $134.0M | +193.9% |
| FY2021 | $45.6M | -9.0% |
| FY2020 | $50.1M | +15660.4% |
| FY2019 | $318,000 | -31.3% |
| FY2018 | $463,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice